Showing results (621-630 of 2,831) with videos related to
Sort By:
Pageof 284
Nanomedicine (London, England)|April 1, 2020
Nanomagnetic liposome-encapsulated parthenolide and indocyanine green for targeting and chemo-photothermal antitumor therapyWenbin Gao, Lei Li, Xuwu Zhang, et al.Nanomedicine (London, England)|September 25, 2020
Colonic delivery of vasoactive intestinal peptide nanomedicine alleviates colitis and shows promise as an oral capsuleDulari Jayawardena, Arivarasu N Anbazhagan, Shubha Priyamvada, et al.Nanomedicine (London, England)|March 8, 2021
Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectivesHamid Rashidzadeh, Hossein Danafar, Hossein Rahimi, et al.Nanomedicine (London, England)|June 30, 2021
In vivo efficacy of meglumine antimoniate-loaded nanoparticles for cutaneous leishmaniasis: a systematic reviewMeliana Borilli Pereira, Bruna Gomes Sydor, Karla Gabriela Memare, et al.Nanomedicine (London, England)|January 27, 2021
Determination of trigonelline in human plasma by magnetic solid-phase extraction: a pharmacokinetic studyNeda Mohamadi, Fariba Sharififar, Mostafa Pournamdari, et al.Nanomedicine (London, England)|January 10, 2022
A review of recent advances in magnetic nanoparticle-based theranostics of glioblastomaDhruba Dhar, Swachhatoa Ghosh, Soumen Das, et al.Nanomedicine (London, England)|July 27, 2021
EGFRvIII peptide nanocapsules and bevacizumab nanocapsules: a nose-to-brain multitarget approach against glioblastomaAline de Cristo Soares Alves, Vladimir Lavayen, Amanda de Fraga Dias, et al.Nanomedicine (London, England)|September 17, 2021
Folate receptor-mediated delivery of 1-MDT-loaded mesoporous silica magnetic nanoparticles to target breast cancer cellsNastaran Hashemzadeh, Mitra Dolatkhah, Ayuob Aghanejad, et al.Nanomedicine (London, England)|April 4, 2022
Dual-function hybrid nanoparticles with gene silencing and anti-inflammatory effectsOksana Fihurka, Vasyl Sava, Juan Sanchez-RamosNanomedicine (London, England)|October 17, 2022
Recent advances in mesoporous silica nanoparticle-based targeted drug-delivery systems for cancer therapyYing Li, Guoxing Deng, Xianlong Hu, et al.Pageof 284